Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotypic and Phenotypic Characteristics of Co-Trimoxazole-Induced Cutaneous Adverse Reactions.

Dermatology (Basel, Switzerland) - 1 Jan 2023

Iamsumang Wimolsiri, Chanprapaph Kumutnart, Sukasem Chonlaphat, Satapornpong Patompong, Thadanipon Kunlawat, Suchonwanit Poonkiat, Jantararoungtong Thawinee, Anuntrangsee Tanaporn

Abstract excerpt

BACKGROUND: Co-trimoxazole has been reported as a common culprit drug for various cutaneous adverse drug reactions (CADRs). However, information on genotypic and phenotypic characteristics is still limited. We aimed to study clinical characteristics, genetic suitability, laboratory findings, and treatment outcomes in patients with co-trimoxazole-induced CADR and determine variables associated with severe...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cicatrix
Share to HIV Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA-A Antigens

Share to HLA-B Antigens

Share to HLA-DRB1 Chains

Share to Stevens-Johnson Syndrome

Share to Trimethoprim, Sulfamethoxazole Drug Combination

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 37793359
DOI: 10.1159/000534342
PMCID: PMC10711762

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotypic and Phenotypic Characteristics of Co-Trimoxazole-Induced Cutaneous Adverse Reactions.PMID 37793359Read ↗

Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions.Semantic proximity Read ↗

HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug Reactions.Semantic proximity Read ↗

Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians.Semantic proximity Read ↗

HLA-B Alleles with Shared Peptide Binding Specificities Define Global Risk of Cotrimoxazole-induced SCARSemantic proximity Read ↗

Human Leukocyte Antigens and Sulfamethoxazole/Cotrimoxazole-Induced Severe Cutaneous Adverse Reactions: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Demographics, Overlap, and Latency of Severe Cutaneous Adverse Reactions in an FDA DatabaseSemantic proximity Read ↗

Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.Semantic proximity Read ↗

Pharmacogenomics of drug-induced hypersensitivity reactions: challenges, opportunities and clinical implementation.Semantic proximity Read ↗

Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes.Semantic proximity Read ↗

Genetics of Severe Cutaneous Adverse ReactionsSemantic proximity Read ↗

Exploring recent advances in drugs severe cutaneous adverse reactions immunopathology.Semantic proximity Read ↗

Epidemiology of severe drug hypersensitivity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.